The FDA’s draft guidance on CBD enforcement policy was submitted for review by the White House Office of Management and Budget (OMB) and the OMB has now scheduled meetings with various hemp/CBD stakeholder groups
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields